Only one in four US patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an analysis of US pharmacy claims that also showed a steady decline in use over time.
#News #wegovy #ozempic #weightloss #usa #health #Reuters #Newsfeed
Read the story here: [ Ссылка ]
👉 Subscribe: [ Ссылка ]
Keep up with the latest news from around the world: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
